Value-based purchasing not linked to improvements in quality

Editor's Note

In this study, Medicare’s Hospital Value-Based Purchasing (HVBP) program was not associated with improvements in quality measures of clinical process or patient experience.

HVBP also was not associated with a significant reduction in two of three mortality measures (ie, acute myocardial infarction or heart failure). It was associated with a significant reduction in mortality in pneumonia patients.

Results suggest that HVBP, which introduced quality performance-based adjustments in Medicare payments, has resulted in little tangible benefit over its first 4 years, the authors say.

Our apologies. An error occurred while setting your user cookie. Please set your browser to accept cookies to continue.